Does Oral Pregabalin Have Side Effects?
Yes, oral pregabalin tablets definitely cause side effects, with the most common being dizziness and somnolence (sleepiness), which occur in a dose-dependent manner and can significantly impact daily functioning. 1, 2
Most Common Side Effects
The primary adverse effects you should expect with pregabalin include:
Neurological Effects (Most Frequent)
- Dizziness: Occurs in 21-29% of patients at therapeutic doses (300-600 mg/day) versus only 5-8% with placebo 1, 2
- Somnolence: Affects 12-16% at 300 mg/day and up to 25% at 600 mg/day, compared to 3-6% with placebo 1, 2
- Ataxia and incoordination: More common at higher doses (3-4% of patients) 2
- Confusion and cognitive difficulties: Particularly "thinking abnormal" (concentration/attention problems) in approximately 2% of patients 1
Other Common Effects
- Peripheral edema: Occurs in 9-12% of patients, which can be particularly problematic for those with heart failure 1, 2
- Weight gain: Affects approximately 4-6% of patients and may complicate diabetes management 1, 2
- Blurred vision: Reported in 4-6% of patients 2
- Dry mouth: Common complaint across studies 2
Dose-Dependent Pattern
The frequency and severity of side effects increase with higher doses. At 300 mg/day, dizziness occurs in approximately 23% of patients, while at 600 mg/day this increases to 29%. Similarly, somnolence increases from 13% to 16% as doses escalate 1. This is clinically important because doses above 300 mg/day are not consistently more effective but are associated with greater adverse effects 1.
Serious but Less Common Side Effects
Life-Threatening Reactions (Rare)
- Angioedema: Swelling of face, mouth, lips, tongue, throat, or neck requiring immediate discontinuation 2
- Hypersensitivity reactions: Including rash, hives, and breathing difficulties 2
- Respiratory depression: Particularly when combined with opioids or in patients with pre-existing breathing problems 2
Other Significant Effects
- Suicidal ideation: Like other antiepileptic drugs, pregabalin carries a risk of suicidal thoughts (approximately 1 in 500 patients) 2
- Muscle problems: Including myalgia and potential creatine kinase elevations 2
- Sexual dysfunction: Not infrequent, including erectile dysfunction (51.6% of affected males), anorgasmia (32.3%), and loss of libido (35.5%). Notably, these can occur at low doses (50-100 mg/day) and are not dose-related 3
- Severe constipation: Can be disabling in some patients (7.5% in one series), is dose-dependent, and may lead to unnecessary investigations if not recognized 4
Important Clinical Caveats
Drug Interactions
Pregabalin's side effects are amplified when combined with:
- Opioids: Increased risk of dizziness, sleepiness, and life-threatening respiratory depression 2
- Benzodiazepines or sedatives: Enhanced sedation and dizziness 2
- ACE inhibitors: Higher risk of swelling and hives 2
- Thiazolidinediones (rosiglitazone, pioglitazone): Increased weight gain and peripheral edema 2
Special Populations
- Renal impairment: Requires dose reduction as pregabalin is renally cleared 1
- Elderly patients: Need lower starting doses and slower titration due to increased sensitivity 1
- Patients with heart failure: Peripheral edema can worsen cardiac status 2
Discontinuation Considerations
Abrupt discontinuation causes withdrawal symptoms including headaches, nausea, diarrhea, insomnia, increased sweating, anxiety, and potentially increased seizure frequency in epilepsy patients. Tapering over at least one week is mandatory 2, 5.
Tolerability Profile
Despite these side effects, pregabalin has a relatively favorable safety profile. Serious adverse events occur at similar rates to placebo (approximately 3% in both groups) 6. Most adverse effects are mild to moderate in intensity 2. However, side effects are the primary reason for treatment discontinuation, occurring in 9-14% of patients (versus 4-7% with placebo), with dizziness and somnolence being the leading causes 2, 6.
The key to minimizing side effects is starting at low doses (50-75 mg twice daily or 150 mg/day) and titrating gradually based on tolerability 1.